These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 11848521)
1. Perspectives in the treatment of malignant gliomas in adults. Andratschke N; Grosu AL; Molls M; Nieder C Anticancer Res; 2001; 21(5):3541-50. PubMed ID: 11848521 [TBL] [Abstract][Full Text] [Related]
2. A review of current and future treatment strategies for malignant astrocytomas in adults. Nieder C; Nestle U Strahlenther Onkol; 2000 Jun; 176(6):251-8. PubMed ID: 10897251 [TBL] [Abstract][Full Text] [Related]
3. Radiochemotherapy of malignant glioma in adults. Clinical experiences. Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711 [TBL] [Abstract][Full Text] [Related]
4. Treatment of malignant gliomas: radiotherapy, chemotherapy and integration of new targeted agents. Nieder C; Grosu AL; Mehta MP; Andratschke N; Molls M Expert Rev Neurother; 2004 Jul; 4(4):691-703. PubMed ID: 15853588 [TBL] [Abstract][Full Text] [Related]
5. Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas. Jansen M; de Witt Hamer PC; Witmer AN; Troost D; van Noorden CJ Brain Res Brain Res Rev; 2004 Jul; 45(3):143-63. PubMed ID: 15210301 [TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic application of noncytotoxic molecular targeted therapy in gliomas: growth factor receptors and angiogenesis inhibitors. Idbaih A; Ducray F; Sierra Del Rio M; Hoang-Xuan K; Delattre JY Oncologist; 2008 Sep; 13(9):978-92. PubMed ID: 18779539 [TBL] [Abstract][Full Text] [Related]
8. Radiotherapy in supratentorial gliomas. A study of 821 cases. Heesters M; Molenaar W; Go GK Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126 [TBL] [Abstract][Full Text] [Related]
9. Recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2) immunotherapy with ranimustine chemotherapy and concurrent radiation therapy for malignant astrocytomas. Fukushima T; Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Soma G Anticancer Res; 2003; 23(6a):4473-81. PubMed ID: 14666736 [TBL] [Abstract][Full Text] [Related]
10. The future of antihypertensive treatment. Israili ZH; Hernández-Hernández R; Valasco M Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579 [TBL] [Abstract][Full Text] [Related]
11. Molecular advances of brain tumors in radiation oncology. Noda SE; El-Jawahri A; Patel D; Lautenschlaeger T; Siedow M; Chakravarti A Semin Radiat Oncol; 2009 Jul; 19(3):171-8. PubMed ID: 19464632 [TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)]. Afra D; Sipos L; Vitanovics D Ideggyogy Sz; 2002 Jan; 55(1-2):38-44. PubMed ID: 12122942 [TBL] [Abstract][Full Text] [Related]
13. [Angiogenesis and anti-angiogenic strategies for glioblastoma]. de Boüard S; Guillamo JS Bull Cancer; 2005 Apr; 92(4):360-72. PubMed ID: 15888393 [TBL] [Abstract][Full Text] [Related]
16. [Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma]. Zhou WN; Chen ZP; You C; Mu YG; Sai K; Zhang JY; Zhang XH; Cheng JJ; Xu HC Ai Zheng; 2004 Nov; 23(11 Suppl):1555-60. PubMed ID: 15566679 [TBL] [Abstract][Full Text] [Related]